AKAM vs XOMAP · P/E 27, rev $2.17B vs P/E 25, rev $28.5M
Akamai Technologies Inc (AKAM) versus XOMA Royalty Corporation (XOMAP) — a side-by-side from cached financials, not a winner call.
Akamai Technologies Inc (AKAM) is a software - infrastructure company listed on US.
XOMA Royalty Corporation (XOMAP) is a biotechnology company listed on NASDAQ.
Latest reported AKAM revenue for 2026-06-30 was $2.17B. Net income was $185.7M. AKAM currently screens at market cap $11.31B and trailing P/E 26.7.
Latest reported XOMAP revenue for 2024-12-31 was $28.5M. Net income was -$13.8M. Revenue was up 498.7% from 2023-12-31 to 2024-12-31. XOMAP currently screens at market cap $0 and trailing P/E 25.4.
AKAM currently screens at market cap $11.31B and trailing P/E 26.7. XOMAP currently screens at market cap $0 and trailing P/E 25.4.
Not investment advice. Open the AKAM and XOMAP stock pages for the full models.
Not investment advice.